Avail advised Nordic Bioproducts Group on the EUR 30 million funding round by Taaleri’s bioindustry fund, Chilean CMPC and other investors

Avail advised Nordic Bioproducts Group, an Aalto University spin-off, on the EUR 30 million funding round involving Taaleri’s bioindustry fund, Chilean CMPC, one of the world's largest pulp producers and other investors. The company utilizes the side streams of pulp and paper industry to develop high-value products. Nordic Bioproducts Group, founded in 2019, uses its patented AaltocellTM technology to produce microcrystalline cellulose and biocomponents with exceptional added value for various applications. By implementing its bioproducts, bioprocesses, and innovations, the company actively reduces the environmental and social costs associated with industrial production.

The company’s cellulose hybrids are developed from Finnish forest fibers and cellulose-containing industrial and agricultural side and waste streams. These biomaterials offer environmentally sustainable and low-emissions alternatives to fossil raw materials and harmful chemicals. They can replace cotton and artificial fibers in the textile industry, plastic in the packaging industry, and be used in insulation and paints in the construction industry.

https://www.sttinfo.fi/tiedote/taaleris-bioindustry-fund-invests-in-nordic-bioproducts-group-a-company-producing-cellulose-based-materials-with-a-high-processing-value?publisherId=69819297&releaseId=69971223

https://www.taaleribioteollisuus.com/en/news-room/taaleris-bioindustry-fund-invests-nordic-bioproducts-group-company-producing-cellulose-based-materials-high-processing-value

‍

‍

‍

‍

‍